Pregabalin Benefits Patients With Treatment-Resistant Generalised Anxiety Disorder

The 22^nd European College of Neuropsychopharmacology (ECNP) Congress has discussed findings about the treatment of gerneralised anxiety disorder (GAD). The conclusion was that Pregablin is effective as adjunctive therapy if the patients have not responded optimally to 2 previous treatments.

Source:  DocGuide.com